BRIEF-Sanofi To Acquire Vigil Neuroscience For $8 Per Share, Equity Value $470 Million

Reuters

22 May

BRIEF-<a href="https://laohu8.com/S/GCVRZ">Sanofi</a> To Acquire Vigil Neuroscience For $8 Per Share, Equity Value $470 Million

May 21 (Reuters) - Sanofi SA SASY.PA:

PRESS RELEASE: SANOFI TO ACQUIRE VIGIL NEUROSCIENCE, INC., ADDING A NEW INVESTIGATIONAL MEDICINE TO TREAT ALZHEIMER’S DISEASE TO THE NEUROLOGY PIPELINE
SANOFI SA - VIGIL SHAREHOLDERS TO RECEIVE $2 CVR PER SHARE
SANOFI SA - ACQUISITION WILL NOT IMPACT SANOFI'S 2025 FINANCIAL GUIDANCE
SANOFI SA - MADE $40 MILLION STRATEGIC INVESTMENT IN VIGIL
SANOFI SA - DEAL EXPECTED TO CLOSE IN Q3 2025
SANOFI SA - TO BUY VIGIL FOR $8 PER SHARE, EQUITY VALUE $470 MILLION

Source text: ID:nGNX3x9LRY

Further company coverage: SASY.PA

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2537577719"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2537577719\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2537577719?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-22 07:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2537577719","market":"us","top_or_hot":-1,"title":"BRIEF-Sanofi To Acquire Vigil Neuroscience For $8 Per Share, Equity Value $470 Million","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/GCVRZ\">Sanofi</a> To Acquire Vigil Neuroscience For $8 Per Share, Equity Value $470 Million</title></head><body><p><span>May 21 (Reuters)</span><span> - </span><a href=\"https://laohu8.com/S/SNYNF\">Sanofi</a> SA <span>SASY.PA</span>:</p><ul><li><p>PRESS RELEASE: SANOFI TO ACQUIRE VIGIL NEUROSCIENCE, INC., ADDING A NEW INVESTIGATIONAL MEDICINE TO TREAT ALZHEIMER’S DISEASE TO THE NEUROLOGY PIPELINE</p></li><li><p>SANOFI SA - VIGIL SHAREHOLDERS TO RECEIVE $2 CVR PER SHARE</p></li><li><p>SANOFI SA - ACQUISITION WILL NOT IMPACT SANOFI'S 2025 FINANCIAL GUIDANCE</p></li><li><p>SANOFI SA - MADE $40 MILLION STRATEGIC INVESTMENT IN VIGIL</p></li><li><p>SANOFI SA - DEAL EXPECTED TO CLOSE IN Q3 2025</p></li><li><p> SANOFI SA - TO BUY VIGIL FOR $8 PER SHARE, EQUITY VALUE $470 MILLION</p></li></ul><p>Source text: <span>ID:nGNX3x9LRY</span></p><p>Further company coverage: <span>SASY.PA</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Sanofi To Acquire Vigil Neuroscience For $8 Per Share, Equity Value $470 Million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Sanofi To Acquire Vigil Neuroscience For $8 Per Share, Equity Value $470 Million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-05-22 07:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/GCVRZ\">Sanofi</a> To Acquire Vigil Neuroscience For $8 Per Share, Equity Value $470 Million</title></head><body><p><span>May 21 (Reuters)</span><span> - </span><a href=\"https://laohu8.com/S/SNYNF\">Sanofi</a> SA <span>SASY.PA</span>:</p><ul><li><p>PRESS RELEASE: SANOFI TO ACQUIRE VIGIL NEUROSCIENCE, INC., ADDING A NEW INVESTIGATIONAL MEDICINE TO TREAT ALZHEIMER’S DISEASE TO THE NEUROLOGY PIPELINE</p></li><li><p>SANOFI SA - VIGIL SHAREHOLDERS TO RECEIVE $2 CVR PER SHARE</p></li><li><p>SANOFI SA - ACQUISITION WILL NOT IMPACT SANOFI'S 2025 FINANCIAL GUIDANCE</p></li><li><p>SANOFI SA - MADE $40 MILLION STRATEGIC INVESTMENT IN VIGIL</p></li><li><p>SANOFI SA - DEAL EXPECTED TO CLOSE IN Q3 2025</p></li><li><p> SANOFI SA - TO BUY VIGIL FOR $8 PER SHARE, EQUITY VALUE $470 MILLION</p></li></ul><p>Source text: <span>ID:nGNX3x9LRY</span></p><p>Further company coverage: <span>SASY.PA</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250521:nTUA6T8NP8:1","article_id":"2537577719","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2537577719","pubTimestamp":1747869728,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Sanofi To Acquire Vigil Neuroscience For $8 Per Share, Equity Value $470 MillionMay 21 (Reuters) - Sanofi SA SASY.PA:PRESS RELEASE: SANOFI TO ACQUIRE VIGIL NEUROSCIENCE, INC., ADDING A NEW INVES","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"简介-赛诺菲将以每股8美元收购Vigil Neuroscience，股权价值4.7亿美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VIGL":0.9},"content_text":"BRIEF-Sanofi To Acquire Vigil Neuroscience For $8 Per Share, Equity Value $470 MillionMay 21 (Reuters) - Sanofi SA SASY.PA:PRESS RELEASE: SANOFI TO ACQUIRE VIGIL NEUROSCIENCE, INC., ADDING A NEW INVESTIGATIONAL MEDICINE TO TREAT ALZHEIMER’S DISEASE TO THE NEUROLOGY PIPELINESANOFI SA - VIGIL SHAREHOLDERS TO RECEIVE $2 CVR PER SHARESANOFI SA - ACQUISITION WILL NOT IMPACT SANOFI'S 2025 FINANCIAL GUIDANCESANOFI SA - MADE $40 MILLION STRATEGIC INVESTMENT IN VIGILSANOFI SA - DEAL EXPECTED TO CLOSE IN Q3 2025 SANOFI SA - TO BUY VIGIL FOR $8 PER SHARE, EQUITY VALUE $470 MILLIONSource text: ID:nGNX3x9LRYFurther company coverage: SASY.PA ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}